These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 15010342)
1. Protein mis-folding emerges as a "drugable" target for discovery of novel therapies for neuropsychiatric diseases of aging. Trojanowski JQ Am J Geriatr Psychiatry; 2004; 12(2):134-5. PubMed ID: 15010342 [No Abstract] [Full Text] [Related]
2. Phage M13 for the treatment of Alzheimer and Parkinson disease. Messing J Gene; 2016 Jun; 583(2):85-89. PubMed ID: 26869319 [TBL] [Abstract][Full Text] [Related]
3. Tau and Parkinson disease. Spillantini MG; Goedert M JAMA; 2001 Nov; 286(18):2324-6. PubMed ID: 11710900 [No Abstract] [Full Text] [Related]
4. Alpha-synuclein and Parkinson's disease. Golbe LI Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675 [No Abstract] [Full Text] [Related]
5. alpha-Synuclein--a link between Parkinson and Alzheimer diseases? Heintz N; Zoghbi H Nat Genet; 1997 Aug; 16(4):325-7. PubMed ID: 9241262 [No Abstract] [Full Text] [Related]
6. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Goedert M Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313 [TBL] [Abstract][Full Text] [Related]
7. Synuclein aggregation: possible role in traumatic brain injury. Bramlett HM; Dietrich WD Exp Neurol; 2003 Nov; 184(1):27-30. PubMed ID: 14637075 [No Abstract] [Full Text] [Related]